Mirabegron, sold under the brand name Myrbetriq among others, is a medication used to treat overactive bladder. Its benefits are similar to antimuscarinic...
12 KB (927 words) - 05:46, 28 February 2024
Administration (FDA) as a medicine. The medicine is called Mirabegron and is used to treat OAB. Mirabegron is a selective β3-AR agonist that affects the detrusor...
21 KB (2,188 words) - 03:36, 20 October 2023
(DDI). Here vibegron differs from the previous overactive bladder drug mirabegron, which was known to be associated in various drug–drug interactions by...
23 KB (2,109 words) - 02:42, 27 April 2024
has developed the first commercially available β3 adrenergic receptor, mirabegron, which is now licensed in Japan and the U.S. exclusively for treatment...
7 KB (546 words) - 13:06, 12 August 2023
Levosalbutamol Lubabegron Mabuterol Melevodopa Methoxyphenamine Methyldopa Mirabegron Norepinephrine Orciprenaline Oxyfedrine PF-610355 Phenylpropanolamine...
162 KB (16,455 words) - 16:22, 25 May 2024
Outside of US. Mycamine (micafungin sodium) – Anti-fungal Myrbetriq (mirabegron) – Overactive bladder (OAB) – US only; marketed by Pfizer Outside of US...
27 KB (2,449 words) - 01:04, 8 May 2024
has been linked to dementia. β3 adrenergic receptor agonists (e.g., mirabegron, vibegron) may be used, as well. Patients taking oxybutynin and other...
37 KB (3,761 words) - 15:26, 23 May 2024
Levosalbutamol Lubabegron Mabuterol Melevodopa Methoxyphenamine Methyldopa Mirabegron Norepinephrine Orciprenaline Oxyfedrine PF-610355 Phenylpropanolamine...
28 KB (2,336 words) - 18:09, 9 May 2024
Levosalbutamol Lubabegron Mabuterol Melevodopa Methoxyphenamine Methyldopa Mirabegron Norepinephrine Orciprenaline Oxyfedrine PF-610355 Phenylpropanolamine...
32 KB (2,681 words) - 11:10, 25 May 2024
Levosalbutamol Lubabegron Mabuterol Melevodopa Methoxyphenamine Methyldopa Mirabegron Norepinephrine Orciprenaline Oxyfedrine PF-610355 Phenylpropanolamine...
54 KB (5,041 words) - 13:48, 20 May 2024